Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Autor: Nakamura, Yasuhiro a, ∗, Namikawa, Kenjiro b, Kiniwa, Yukiko c, Kato, Hiroshi d, Yamasaki, Osamu e, Yoshikawa, Shusuke f, Maekawa, Takeo g, Matsushita, Shigeto h, Takenouchi, Tatsuya i, Inozume, Takashi j, Nakai, Yasuo k, Fukushima, Satoshi l, Saito, Shintaro m, Otsuka, Atsushi n, o, Fujimoto, Noriki p, Isei, Taiki q, Baba, Natsuki r, Matsuya, Taisuke s, Tanaka, Ryo t, Kaneko, Takahide u, Onishi, Masazumi v, Kuwatsuka, Yutaka w, Nagase, Kotaro x, Onuma, Takehiro y, Nomura, Motoo z, Umeda, Yoshiyasu a, t, Yamazaki, Naoya b
Zdroj: In European Journal of Cancer November 2022 176:78-87
Databáze: ScienceDirect